Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. (NCT06970496) | Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. | 2026-08-31 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia. (NCT06927466) | Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. | 2024-09-19 |
Track Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.